A
$ Value
$0
Shares
409,836
Price
$0
Filed
Mar 12
Insider
Name
MCCOURT Thomas A
Title
Chief Executive Officer
CIK
0001478448
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,898,838
Footnotes
The restricted stock unit award, granted as an annual performance award, vests as to 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
Filing Info
MCCOURT Thomas A's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | IRWD | A | $0 |
| 2026-02-24 | IRWD | ▼ | $379K |
| 2026-02-23 | IRWD | ▼ | $361K |
| 2025-06-05 | PLRX | A | $0 |
| 2025-05-20 | IRWD | A | $0 |
| 2025-05-16 | IRWD | ▼ | $8K |
Other Insiders at IRWD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DENNER ALEXANDER J | — | $20.5M | 2026-03-17 |
|
MCCOURT Thomas A
Chief Executive Officer
|
— | $740K | 2026-02-24 |
|
Shetzline Michael
SVP, CMO, Head-Res&Drug
|
— | $122K | 2026-03-10 |
|
Silver Ronald
Principal Accounting Officer
|
— | $90K | 2026-03-10 |
|
John Minardo
Chief Legal Officer
|
— | $136K | 2026-03-10 |
|
Martini Gregory S.
Chief Financial Officer
|
— | $82K | 2026-03-10 |
|
Gaskins Tammi L
Chief Commercial Officer
|
— | $80K | 2026-03-10 |